Program
First International Symposium on Cardiac Sympathetic Neuroimaging
In conjunction with the 19th International Symposium of the American Autonomic Society (AAS)
Organizers: D. S. Goldstein and S. Orimo
Marriott Kauai Resort Hotel
Lihue, Kauai, Hawaii
October 29, 2008

7:30-8:15  
Buffet breakfast and sign-in
8:15-8:25
Welcome and background. D.S. Goldstein, NINDS, NIH, Bethesda, MD USA
8:25-8:45
D.S. Goldstein, NINDS, NIH, Bethesda, MD USA
Cardiac and extra-cardiac noradrenergic denervation in Parkinson disease (also Poster #S14)
8:45-9:05 
P.H. Lee, Ajou University School of Medicine, Suwon, Korea
Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson’s disease (also Poster #S15)
9:05-9:25
G. Wenning, University of Innsbruck, Austria
Brain and cardiac neuroimaging to distinguish Parkinson’s disease from multiple system atrophy (also Poster #S16)
9:25-9:45
S. Orimo, Kanto Central Hospital, Tokyo, Japan
Cardiac noradrenergic denervation in Lewy body disease: Clinical-pathologic correlations (also Poster #S17)
9:45-10:00
Coffee/juice break
10:00-10:20 
S. Kasama, Gunma University School of Medicine, Gunma, Japan
Effects of candesartan on cardiac sympathetic nerve activity in patients with chronic heart failure and preserved left ventricular ejection fraction (also Poster #S18)
10:20-10:40
T. Ueyama, Wakayama Medical University, Wakayama, Japan
Takotsubo cardiomyopathy: a form of severe, reversible heart failure evoked by emotional distress in post-menopausal women (also Poster #S19)
10:40-11:00
Question and answer session
11:00-12:00
Poster viewing and tour
12:00-2:00
Buffet lunch and roundtable discussion (microphone at each table)
Translating cardiac neuroimaging to clinical research and practice

         

     

Posters

Poster #S1
Differential diagnostic value of normal uptake but increased 123I-MIBG washout in Parkinsonism
Y Uchiyama, M Momose, C Kondo, K Kusakabe, M Iwata, S Uchiyama
Tokyo, Japan
Poster #S2
123I-meta-iodobenzylguanidine scintigraphy is a useful diagnostic tool to differentiate early phase of Lewy body disease from other movement disorders
T Takeda, S Uchiyama
Tokyo, Japan
Poster #S3
123I-MIBG scintigraphy in PSP, CBD and IPD
M Yoshita, D Noto, K Takahashi, M Yamada
Kanazawa, Japan
Poster #S4
Myocardial sympathetic degeneration correlates with olfactory function in Parkinson’s disease
M Iijima, M Osawa, M Momose, M Suzuki, S Uchiyama
Tokyo, Japan
Poster #S5
MIBG myocardial scintigraphy in the diagnosis of dementia
J Nunomura, M Nishie, A Arai, Y Miki, M Baba
Aomori, Japan
Poster #S6
123I-metaiodobenzylguanidine myocardial scintigraphy and susceptibility weighted-imaging of the substantia nigra in patients with PD
T Maeda, K Nagata, H Toyoshima, T Kinoshita
Akita, Japan
Poster #S7
Longitudinal observation of MIBG myocardial scintigraphy in patients with multiple system atrophy
H Nagayama, M Ueda, M Hamamoto, K Tsukamoto, Y Katayama
Tokyo, Japan
Poster #S8
Preclinical investigation of 11C-phenethylguanidines as radiotracers for quantifying cardiac sympathetic nerve density with PET
DM Raffel, Y-W Jung, G Gu, RA Koeppe, P Sherman, C Quesada
Ann Arbor, MI, USA
Poster #S9
PET measurement of cardiac and nigrostriatal denervation in parkinsonian syndromes
DM Raffel, RA Koeppe, R Little, C-N Wang, S Liu, L Junck, M Heumann, S Gilman
Ann Arbor, MI, USA
Poster #S10
Importance of renal function of cardiac iodine-123 metaiodobenzylguanidine scintigraphy for predicting prognosis of heart disease patients
T Furuhashi, M Moroi, H Hase, T Kunimasa, R Nakazato, H Fukuda, K Sugi
Tokyo, Japan
Poster #S11
Marked reduction of cardiac 123I-MIBG uptake in REM sleep behavior disorder compared with Parkinson’s disease
K Kashihara, T Imamura, M Ohno, S Kawada
Okayama, Japan
Poster #S12
Evaluation of Parkinson’s disease and related disorders using cardiac MIBG scintigraphy
K Marumoto, K Ichikawa, R Yamada, H Kikuchi, M Nakashita, K Matsumoto, Y Kageyama
Hyogo, Japan
Poster #S13
Translating cardiac neuroimaging to clinical practice: a novel approach to neurogenic orthostatic hypotension
DS Goldstein, Y Sharabi
Bethesda, MD, USA